期刊文献+

FHL1与COPD大鼠肺血管重塑的关系及其机制 被引量:2

Relationship between pulmonary vascular remodeling and FHL1 in rats with COPD and its mechanism
原文传递
导出
摘要 目的探讨FHL1与COPD大鼠肺血管重塑的关系及肺动脉平滑肌细胞增殖及表型转换在其中的作用。方法将20只雄性SD大鼠随机分为正常组及COPD组,每组10只。COPD组香烟烟雾暴露80 d复制COPD模型。图像分析法测定肺小动脉管壁厚度占外径的百分比(WT%)和管壁面积占血管总面积的百分比(WA%)。Western-blot法检测肺组织FHL1蛋白,荧光定量PCR法检测肺组织FHL1 mRNA。免疫组化法检测肺小动脉FHL1、α-actin及vimentin;PCNA法检测肺动脉平滑肌增殖细胞的阳性细胞率(PI);t检验及直线相关进行数据分析。结果 COPD组WT%和WA%较正常组升高(P<0.05),COPD组肺组织FHL1蛋白及mRNA(133.250±25.499和4.963±0.692)较正常组(51.188±18.259和1.697±0.360)升高(P<0.05)。COPD组肺小动脉FHL1、vimentin、α-actin及PI(0.316±0.093、0.085±0.030、0.219±0.049和0.575±0.076)较正常组(0.241±0.093、0.069±0.023、0.163±0.042和0.429±0.092)升高(P<0.05)。肺小动脉FHL1表达与WT%、WA%、vimentin及PI呈正相关(P<0.05),但肺小动脉FHL1表达与α-actin表达无相关性(P>0.05)。结论 COPD大鼠肺血管FHL1增加与肺血管重塑相关,FHL1可能通过增加肺血管平滑肌细胞增殖及促进平滑肌细胞合成表型转换参与COPD肺血管重塑。 Objective To evaluate the relationship of Four-and-a-half LIM domain 1 ( FHL1 ) and pulmonary artery remodeling in rats with chronic obstructive pulmonary disease(COPD) and to study the role of pulmonary artery smooth muscle cell proliferation and phenotype transformation in this course. Methods Twenty adult male SD rats were randomly divid- ed into two groups, one group( 10 adult male rats) was exposed to air( control group)and the other group (10 adult male rats) was exposed to cigarette smoke for 80 days (COPD group). Image analysis was used to calculate the ratio of thick- ness/outside diameter of pulmonary arterioles( WT% ) and the ratio of vessel wall area/total vessel area( WA% ). The levels of FHL1 and FHL1 mRNA in rat pulmonary were determined by Westeru-blot test and Real time fluorescent quantitative PCR. lmmunohistoehemistry was used to determine FHL1, α-actin and vimentin in pulmonary arterioles smooth muscle. PCNA was used to determine the proliferation level of pulmonary arterioles smooth muscle cell ( PI ). The data were analyzed by T-test and linear correlation analysis. Results The WT% and WA% of COPD group were higher than control group(P 〈 0.05). The levels of FHL1 and FHLlmRNA in pulmonary of COPD group (133. 250 25. 499 and 4.963 ± 0. 692) were higher than control group (51. 188 s 18. 259 and 1. 697 s 0.360) ( P 〈 0.05 ). The levels of FHL1, vimentin,α-actin and PI on pulmonary arterioles of COPD group(0. 316 ± 0. 093,0. 085 ± 0. 030,0. 219± 0. 049 and 0.575 ± 0. 076 ) were higher than control group(0. 241 ±0. 093,0. 069 ±0. 023,0. 163 ±0. 042 and 0. 429 ±0. 092) ( P 〈 0.05 ). The levels of FHL1 on pulmonary arterioles was positively related to WA% , WT% , vimentin and PI ( P 〈 0. 05 ), but did not to α-actin. Conclusion The elevation of FHL1 level in pulmonary artery of COPD group is related to pulmonary artery remodeling. FHL1 may cause pulmonary artery remodeling by increasing proliferation of pulmonary arterioles smooth muscle cell and inducing the transformation of phenotype of pulmonary arteriole smooth muscle.
出处 《中华全科医学》 2014年第11期1727-1729,F0003,共4页 Chinese Journal of General Practice
基金 浙江省自然科学基金(LQ13H010002) 浙江省温州市科技局项目(Y20100292)
关键词 COPD FHL1 肺血管 平滑肌 Chronic obstructive pulmonary disease FHL1 Pulmonary vessels Smooth muscles
  • 相关文献

参考文献12

  • 1Anna Sarkozy, Christian Windpassinger, Judith Hudson, et al. Pheno- typic heterogeneity in British patients with a founder mutation in the FHL1 gene [ J ]. European Journal of Human Genetics,2011,19 ( 10 ) :1038-1044.
  • 2Kwapiszewska G,Wygrecka M,Marsh LM,et al. Fhl-1 ,a new key pro- tein in pulmonary hypertension [ J ]. Circulation, 2008, 118 ( 11 ) : 1183-1194.
  • 3李军利,陈平,蔡珊,张程,裴艳芳,王伟,刘绍坤.AP-2α在烟雾暴露所致慢性阻塞性肺疾病大鼠肺组织中的表达及与肺间隔细胞凋亡的关系[J].国际呼吸杂志,2009,29(9):528-533. 被引量:2
  • 4D' Arcy CE, Feeney SJ, McLean CA, et al. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy [ J ]. Hum Mol Genet,2014,23 (3) :618-636.
  • 5Tiffin HR, Jenkins ZA, Gray M J, et al. Dysregulation of FHL1 splice- forms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype [ J ]. Neurogenetics ,2013,14 (2) : 113-121.
  • 6Wilding BR, McGrath MJ, Bonne G, et al. FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and im- pair myoblast differentiation [ J ]. J Cell Sci, 2014,127 ( Ptl 0 ) : 2269- 2281.
  • 7Friedrich FW, Wilding BR, Reischmann S, et al. Evidence of FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy [ J ]. Hum Mol Genet,2012,21 ( 14 ) :3237-3254.
  • 8Christodoulou DC, Wakimoto H, Onoue K, et al. 5' RNA-Seq identifies Fhll as a genetic modifier in cardiomyopathy[ J]. J Clin Invest ,2014, 124(3) :1364-1370.
  • 9Weng J, Liao M, Zou S, et al. Downregulation of FHL1 expression in thoracic aortic dissection: implications in aortic wall remodeling and pathogenesis of thoracic aortic dissection [ J ]. Ann Vasc Surg,2011,25 (2) :240-247.
  • 10Niu C, Liang C, Guo J, et al. Downregulation and growth inhibitory role of FHL1 in lung cancer [ J ]. International Journal of Cancer, 2012,130( 11 ) :2549-2556.

二级参考文献21

  • 1陈劲龙,冉丕鑫.血管内皮生长因子与烟雾暴露所致大鼠肺气肿发病关系的研究[J].中华结核和呼吸杂志,2003,26(11):671-674. 被引量:22
  • 2陈涛,吴亚梅.胶原酶/组织金属蛋白酶抑制剂-1免疫活性及其在慢性阻塞性肺疾病肺结构改变中的作用[J].中国呼吸与危重监护杂志,2004,3(6):387-391. 被引量:18
  • 3Kasahara Y,Tuder RM,Cool CD,et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med, 2001,163 (3 Pt 1 ) : 737-744.
  • 4Zhang J, Hagopian-Donaldson S, Serbedzija G, et al. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature, 1996,381 : 238-241.
  • 5Zeng YX,Somasundaram K,el-Deiry WS. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat Genet, 1997,15 : 28-32.
  • 6Muller FU, Loser K, Kleideiter U, et al. Transcription factor AP-2alpha triggers apoptosis in cardiac myoeytes. Cell Death Differ, 2004,5 : 485-493.
  • 7Schreiber E,Matthias P,Mtiller MM,et al. Rapid detection of octamer binding proteins with 'mini-extracts'prepared from a small number of cells. Nucleic Acids Res, 1989,17 : 6419.
  • 8No authors listed. The definition of emphysema. Report of a National, Heart, Lung and Blood Institute. Division of Lung Diseases workshop. Am Rev Respir Dis, 1985,132 : 182-185.
  • 9Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol,2003,28:555-562.
  • 10Taraseviciene-Stewart L, Douglas IS, Nana-Sinkam PS, et al. Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease?. Proc Am Thorac Soc, 2006,3:687-690.

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部